Addressing Manufacturing Cost Inflation Through Higher Selling Prices and Expense Control
First written in FY2023-Q3. 6 of 7 entries say "Advanced", first in FY2023. Latest entry: FY2026.
39 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Gross profit increased 6.1% year on year to ¥594.7 billion, despite the impact of U.S. tariff policy, owing to higher revenue.」
The company continued to address inflation and tariffs through productivity improvements, cost reductions and investment in production capacity in high-growth areas. Despite the impact of tariff policy, gross profit increased 6.1%. - 2026-05-15AdvancedEarnings
「In fields expected to achieve high growth, we plan to continue capital investment, centered on expanding production capacity.」
The Company indicated that it would pursue growth investment while addressing inflation and cost pressures, and continue expanding production capacity. - FY2025AdvancedAnnual report
「Under these circumstances, the earnings forecast anticipates increases in revenue and adjusted operating profit. The company will continue to implement appropriate measures suited to market conditions, including improvements in productivity at manufacturing sites and cost reduction measures.」
The company indicated a policy of continuing to address inflation and higher raw material costs through productivity improvements, cost reductions and investment in production capacity in high-growth areas. - FY2025-H1AdvancedAnnual report
「In Japan, revenue increased 7.5% year on year as demand expanded for the Hospital Care Solutions and Pharmaceutical Solutions businesses, with pricing policy also contributing.」
Profit improvement measures, including pricing policy, contributed to Japan revenue for the Medical Care Solutions Company, which increased 7.5% year on year. - FY2024AdvancedAnnual report
「Under these circumstances, the earnings forecast incorporates appropriate measures suited to market conditions, including improvements in productivity at manufacturing sites and cost reduction measures. In areas expected to achieve high growth, the company will focus on capital investment, primarily to expand production capacity.」
Specified the response to manufacturing cost inflation as improvements in production-site productivity, cost reduction measures and investment in production capacity in high-growth areas. - FY2023AdvancedAnnual report
「The earnings forecast incorporates measures including a further review of pricing policy, including price increases, more efficient cost management and bringing forward cost reduction measures.」
Expanded the response to manufacturing cost inflation to include further pricing reviews, cost efficiencies and bringing forward cost reduction measures. In growth areas, the company indicated a policy of actively increasing capital investment, primarily to expand production capacity. - FY2023-Q3First statedAnnual report
「Adjusted operating profit increased as higher manufacturing costs due to inflation were partially offset by the effect of higher revenue, price increases and tighter cost controls.」
For the first time, identified price increases and tighter cost controls as separate measures to address manufacturing cost inflation.